[Experimental studies on the mode of action of substances promoting radioresistance].
D000262:Adenylyl Cyclases / Q000378:metabolism*; D000818:Animals; D002110:Caffeine / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism*; D004347:Drug Interactions; D005260:Female; D007274:Injections, Intraperitoneal; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011833:Radiation Injuries, Experimental; D011837:Radiation-Protective Agents / Q000008:administration & dosage / Q000494:pharmacology*; D011879:Radiotherapy Dosage; D011955:Receptors, Drug
D011837:Radiation-Protective Agents; D011955:Receptors, Drug; D002110:Caffeine; D011433:Propranolol; D000242:Cyclic AMP; D000262:Adenylyl Cyclases; D010646:Phentolamine
Experimentelle Untersuchungen zum Wirkungsmechanismus strahlenresistenzerhöhender Substanzen.